The Acceptability, Feasibility, and Efficacy (Phase I/II Study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) Intervention to Improve Dyspareunia and Alleviate Sexual Problems in Women with Breast Cancer

Journal of Sexual Medicine

Volumn 10, Issue 10, 2013, Pages 2549-2558

  Juraskova, Ilona ^a   Jarvis, Sherin ^b,c   Mok, Kelly ^d,e   Peate, Michelle ^d,e   Meiser, Bettina ^d,e   Cheah, Benjamin C ^f   Mireskandari, Shab ^a   Friedlander, Michael ^d,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Breast Cancer; Dyspareunia; Pelvic Floor Muscle Relaxation Exercises; Sexual Functioning; Vaginal Dryness; Vaginal Lubricant Moisturizer

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN; GOSERELIN; LUBRICATING AGENT; OLIVE OIL; PLACEBO; POLYCARBOPHIL; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CONSTIPATION; CONTROLLED STUDY; DEMOGRAPHY; DISTRESS SYNDROME; DYSPAREUNIA; ELECTROMYOGRAPHY; EXERCISE; FEASIBILITY STUDY; FEMALE; FEMALE SEXUAL DYSFUNCTION; FOLLOW UP; HORMONE SUBSTITUTION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMIDIFIER; LEISURE; MAJOR CLINICAL STUDY; MANOMETRY; MARRIAGE; MASTECTOMY; MUSCLE RELAXATION; OVARIECTOMY; PAIN ASSESSMENT; PARTIAL MASTECTOMY; PELVIC FLOOR DISORDER; PELVIS FLOOR; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHYSIOTHERAPIST; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELAXATION TRAINING; SCREENING; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SEXUALITY; URINE INCONTINENCE; VAGINA EPITHELIUM; VAGINAL DRYNESS; VAGINAL EXERCISE; VISUAL ANALOG SCALE;

BREAST CANCER; DYSPAREUNIA; PELVIC FLOOR MUSCLE RELAXATION EXERCISES; SEXUAL FUNCTIONING; VAGINAL DRYNESS; VAGINAL LUBRICANT/MOISTURIZER;

ADULT; AGED; BIOFEEDBACK, PSYCHOLOGY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DYSPAREUNIA; EMOLLIENTS; EXERCISE THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; LIPIDS; LUBRICANTS; MIDDLE AGED; MUSCLE RELAXATION; PATIENT SATISFACTION; PELVIC FLOOR; PLANT OILS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84885942576     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12156     Document Type: Article

References (37)

1. Minton S, Munster P. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 2002;9:466-472.
2. Bines J, Oleske D, Cobleigh M. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-1729.
3. Goodwin P, Ennis M, Pritchard K, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999;17:2365-2370.
4. Hickey M, Saunders C, Partridge A, Santoro N, Joffe H, Stearns V. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 2008;19:1669-1680.
5. Thors C, Broeckel J, Jacobsen P. Sexual functioning in breast cancer survivors. Cancer Control 2001;8:442-448.
6. Barni S, Mondin R. Sexual dysfunction in treated breast cancer patients. Ann Oncol 1997;8:1-5.
7. Ganz P, Rowland J, Desmond K, Meyerowitz B, Wyatt G. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-514.
8. Lindley C, Vasa S, Sawyer W, Winer E. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998;16:1380-1387.
9. Reissing E, Binik Y, Khalife S. Does vaginismus exist? A critical review of the literature. J Nerv Ment Dis 1999;187:261-274.
10. Cox A, Jenkins V, Catt S, Langridge C, Fallowfield L. Information needs and experiences: An audit of UK cancer patients. Eur J Oncol Nurs 2006;10:263-272.
11. Hordern AJ, Street AF. Communicating about patient sexuality and intimacy after cancer: Mismatched expectations and unmet needs. Med J Aust 2007;186:224-227.
12. Holmberg L, Anderson H. HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: Trial stopped. Lancet 2004;363:453-455.
13. Schoultz E, Rutqvist L. Menopausal hormone therapy after breast cancer: The Stockholm randomized trial. J Natl Cancer Inst 2005;97:533-535.
14. Kendall A, Dowsett M. Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584-587.
15. Ganz P, Greendale G, Petersen L, Zibecchi L, Kahn B, Belin T. Managing menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial. J Natl Cancer Inst 2000;92:1054-1064.
16. Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 2011;8:549-559.
17. Herbenick D, Reece M, Hensel D, Sanders S, Jozkowski K, Fortenberry JD. Association of lubricant use with women's sexual pleasure, sexual satisfaction, and genital symptoms: A prospective daily diary study. J Sex Med 2011;8:202-212.
18. Sutton KS, Boyer SC, Goldfinger C, Ezer P, Pukall CF. To lube or not to lube: Experiences and perceptions of lubricant use in women with and without dyspareunia. J Sex Med 2012;9:240-250.
19. Adriaens E, Remon JP. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis 2008;35:512-516.
20. Goldstein I, Meston CM, Davis SR, Traish AR. Women's sexual function and dysfunction: Study, diagnosis and treatment. London: Taylor & Francis Group; 2006:760pp.
21. Goldenberg R, White R. The effect of vaginal lubricants on sperm motility in vitro. Fertil Steril 1975;26:872-873.
22. Andreson L, Lewis S, McClure N. The effects of coital lubricants on sperm motility in vitro. Hum Reprod 1998;13:3351-3356.
23. Kutteh W, Chao C, Ritter J, Byrd W. Vaginal lubricants for the infertile couple: Effect on sperm activity. Int J Fertil Menopausal Stud 1996;41:400-404.
24. Loprinzi C, Abu-Ghazaleh S, Sloan J, vanHaelst-Pisani C, Hammer A, Rowland JR, Law M, Windschitle HE, Kaur JS, Ellison N. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 1997;15:969-973.
25. Bygdeman M, Swahn ML. Replens® versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 2006;23:259-263.
26. Van der Laak J, de Bie L, de Leeuw H, Meyerowitz B, Wyatt G. The effect of Replens® on vaginal cytology in the treatment of postmenopausal atrophy: Cytomorphology versus computerised cytometry. J Clin Pathol 2002;55:446-451.
27. Koh C, Young C, Young J, Solomon M. Systemic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. Br J Surg 2008;95:1079-1087.
28. Glazer HI, Laine CD. Pelvic floor muscle biofeedback in the treatment of urinary incontinence: A literature review. Appl Psychophysiol Biofeedback 2006;31:187-201.
29. Rosenbaum TY. Pelvic floor involvement in male and female sexual dysfunction and the role of pelvic floor rehabilitation in treatment: A literature review. J Sex Med 2007;4:4-13.
30. Carlsson A. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983;16:87-101.
31. Thirlaway K, Fallowfield L, Cuzick J. The Sexual Activity Questionnaire: A measure of women's sexual functioning. Qual Life Res 1996;5:81-90.
32. Monahan PO, Champion VL, Zhao QQ, Miller AM, Gershenson D, Williams SD, Cella D. Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: A gynecologic oncology group study. J Psychosoc Oncol 2008;26:19-42.
33. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
34. Brady M, Cella D, Mo F, Bonomi A, Tulsky D, Lloyd S, Deasy S, Cobleigh M, Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 1997;15:974-986.
35. Fallowfield L, Leaity S, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 1999;55:189-199.
36. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
37. Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev 2010;Issue 9.Art.No.:CD007291.